BGM GroupBGM +13.07%53 Market Cap is $74.63 Mil as of Jun. 29, 2026. GuruFocus rates BGM with a GF Score™ of 53/100. Among 1,020 Drug Manufacturers companies, BGM Group ranks worse than 65.49% on this metric.
Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). BGM Group's share price for the quarter that ended in Mar. 2025 was $11.44. BGM Group's Shares Outstanding (EOP) for the quarter that ended in Mar. 2025 was 98.30 Mil. Therefore, BGM Group's market cap for the quarter that ended in Mar. 2025 was $1,124.49 Mil.
BGM Group's quarterly market cap
increased
from Mar. 2024 ($24.66 Mil) to Sep. 2024 ($57.74 Mil) and
increased
from Sep. 2024 ($57.74 Mil) to Mar. 2025 ($1,124.49 Mil).
BGM Group's annual market cap
declined
from Sep. 2022 ($42.54 Mil) to Sep. 2023 ($28.14 Mil) but then
increased
from Sep. 2023 ($28.14 Mil) to Sep. 2024 ($57.74 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. BGM Group's Enterprise Value for Today is $63.24 Mil.
BGM Group (NAS:BGM) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
BGM Group Market Cap Related Terms
BGM Group Market Cap Historical Data
* Premium members only.
The historical data trend for BGM Group's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, BGM Group's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
BGM Group Market Cap vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, BGM Group's Market Cap distribution charts can be found below:
* The bar in red indicates where BGM Group's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
BGM Group's Market Cap for the fiscal year that ended in Sep. 2024 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BGM Group (BGM) has a Market Cap of $74.63 Mil as of Jun. 29, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on BGM Group and its competitors. According to the industry distribution chart, BGM Group ranks #668 out of 1020 companies in the Drug Manufacturers industry, placing it in the top 65.5%.
Is BGM Group's Market Cap too high?
BGM Group's current Market Cap is $74.63 Mil. The Drug Manufacturers industry median Market Cap is 206.61. BGM Group's value of $74.63 Mil is 63.9% below this industry median. Based on the distribution chart, BGM Group ranks #668 out of 1020 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, BGM Group has a GF Score™ of 53/100, reflecting its overall financial health beyond just this single metric.
How does BGM Group's Market Cap compare to INCR and SCYX?
According to the Drug Manufacturers industry distribution chart, BGM Group ranks #668 out of 1020 companies for Market Cap. This places BGM Group in the lower half of its industry. The industry median Market Cap is 206.61. BGM Group's value of $74.63 Mil is 63.9% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Drug Manufacturers company?
The median Market Cap among Drug Manufacturers companies is 206.61, based on 1,020 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. BGM Group's current Market Cap of $74.63 Mil is 63.9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on BGM Group and its competitors. For the Drug Manufacturers industry, the median Market Cap is 206.61 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. BGM Group's current Market Cap is $74.63 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is BGM Group stock overvalued right now?
BGM Group (BGM) has a current Market Cap of $74.63 Mil. The current Market Cap is $74.63 Mil and 63.9% below the Drug Manufacturers industry median of 206.61. BGM Group's overall GF Score™ is 53/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For BGM Group (BGM), the current Market Cap is $74.63 Mil as of Jun. 29, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
BGM Group Ltd is a biopharmaceuticals, bio-extraction, and medical health business. Its product range includes oxytetracycline APIs, licorice preparations, and crude heparin sodium. Maximum revenue is from Oxytetracycline & Licorice and TCMD, followed by Heparin products and Sausage casing.
53GF Score
Get the complete analysis for BGM
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BGM has been successfully added to your 
